Luteolin, an aryl hydrocarbon receptor antagonist, alleviates diabetic retinopathy by regulating the NLRP/NOX4 signalling pathway: Experimental and molecular docking study

Yang, Y; Zhou, M; Liu, H

Yang, Y (corresponding author), Dalian Univ, Affiliated Zhongshan Hosp, Dept Ophthalmol, 6 Jiefang St, Dalian 116001, Liaoning, Peoples R China.

PHYSIOLOGY INTERNATIONAL, 2021; 108 (2): 172

Abstract

Objective: The present report evaluates the protective effects of luteolin against diabetic retinopathy (DR). Materials and methods: Diabetes was indu......

Full Text Link